1. Home
  2. DVA vs BRBR Comparison

DVA vs BRBR Comparison

Compare DVA & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • BRBR
  • Stock Information
  • Founded
  • DVA 1994
  • BRBR 2019
  • Country
  • DVA United States
  • BRBR United States
  • Employees
  • DVA N/A
  • BRBR N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • BRBR Packaged Foods
  • Sector
  • DVA Health Care
  • BRBR Consumer Staples
  • Exchange
  • DVA Nasdaq
  • BRBR Nasdaq
  • Market Cap
  • DVA 10.9B
  • BRBR 8.8B
  • IPO Year
  • DVA 1995
  • BRBR 2019
  • Fundamental
  • Price
  • DVA $136.18
  • BRBR $62.96
  • Analyst Decision
  • DVA Hold
  • BRBR Strong Buy
  • Analyst Count
  • DVA 4
  • BRBR 18
  • Target Price
  • DVA $157.00
  • BRBR $77.56
  • AVG Volume (30 Days)
  • DVA 828.5K
  • BRBR 2.8M
  • Earning Date
  • DVA 05-12-2025
  • BRBR 05-05-2025
  • Dividend Yield
  • DVA N/A
  • BRBR N/A
  • EPS Growth
  • DVA 14.90
  • BRBR 49.75
  • EPS
  • DVA 10.11
  • BRBR 2.14
  • Revenue
  • DVA $12,968,524,000.00
  • BRBR $2,192,100,000.00
  • Revenue This Year
  • DVA $6.00
  • BRBR $17.77
  • Revenue Next Year
  • DVA $3.66
  • BRBR $11.06
  • P/E Ratio
  • DVA $13.48
  • BRBR $29.39
  • Revenue Growth
  • DVA 5.11
  • BRBR 18.91
  • 52 Week Low
  • DVA $131.76
  • BRBR $48.06
  • 52 Week High
  • DVA $179.60
  • BRBR $80.67
  • Technical
  • Relative Strength Index (RSI)
  • DVA 37.73
  • BRBR 42.52
  • Support Level
  • DVA $136.50
  • BRBR $60.09
  • Resistance Level
  • DVA $140.42
  • BRBR $63.84
  • Average True Range (ATR)
  • DVA 3.66
  • BRBR 2.07
  • MACD
  • DVA -0.59
  • BRBR -0.02
  • Stochastic Oscillator
  • DVA 11.71
  • BRBR 45.48

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About BRBR BellRing Brands Inc.

BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.

Share on Social Networks: